These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31883446)

  • 41. Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.
    Rodrigues CA; Frade RF; Albuquerque IS; Perry MJ; Gut J; Machado M; Rosenthal PJ; Prudêncio M; Afonso CA; Moreira R
    ChemMedChem; 2015 May; 10(5):883-90. PubMed ID: 25784585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents.
    Katiyar SB; Srivastava K; Puri SK; Chauhan PM
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4957-60. PubMed ID: 16168643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiplasmodial activity of a series of 1,3,5-triazine-substituted polyamines.
    Klenke B; Barrett MP; Brun R; Gilbert IH
    J Antimicrob Chemother; 2003 Aug; 52(2):290-3. PubMed ID: 12837742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. QSAR and pharmacophore modeling of natural and synthetic antimalarial prodiginines.
    Singh B; Vishwakarma RA; Bharate SB
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):350-9. PubMed ID: 24010933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
    Xue L; Shi DH; Harjani JR; Huang F; Beveridge JG; Dingjan T; Ban K; Diab S; Duffy S; Lucantoni L; Fletcher S; Chiu FCK; Blundell S; Ellis K; Ralph SA; Wirjanata G; Teguh S; Noviyanti R; Chavchich M; Creek D; Price RN; Marfurt J; Charman SA; Cuellar ME; Strasser JM; Dahlin JL; Walters MA; Edstein MD; Avery VM; Baell JB
    J Med Chem; 2019 Mar; 62(5):2485-2498. PubMed ID: 30715882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
    Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
    Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
    Biot C; Glorian G; Maciejewski LA; Brocard JS
    J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sontochin as a guide to the development of drugs against chloroquine-resistant malaria.
    Pou S; Winter RW; Nilsen A; Kelly JX; Li Y; Doggett JS; Riscoe EW; Wegmann KW; Hinrichs DJ; Riscoe MK
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3475-80. PubMed ID: 22508305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum.
    Yoshikawa M; Motoshima K; Fujimoto K; Tai A; Kakuta H; Sasaki K
    Bioorg Med Chem; 2008 Jun; 16(11):6027-33. PubMed ID: 18479926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity.
    Hussain H; Specht S; Sarite SR; Saeftel M; Hoerauf A; Schulz B; Krohn K
    J Med Chem; 2011 Jul; 54(13):4913-7. PubMed ID: 21591758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery.
    Quiliano M; Pabón A; Moles E; Bonilla-Ramirez L; Fabing I; Fong KY; Nieto-Aco DA; Wright DW; Pizarro JC; Vettorazzi A; López de Cerain A; Deharo E; Fernández-Busquets X; Garavito G; Aldana I; Galiano S
    Eur J Med Chem; 2018 May; 152():489-514. PubMed ID: 29754074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
    de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
    Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.
    Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV
    Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, in vitro and in silico antimalarial activity of 7-chloroquinoline and 4H-chromene conjugates.
    Parthiban A; Muthukumaran J; Manhas A; Srivastava K; Krishna R; Rao HS
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4657-63. PubMed ID: 26338359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum.
    Burgess SJ; Selzer A; Kelly JX; Smilkstein MJ; Riscoe MK; Peyton DH
    J Med Chem; 2006 Sep; 49(18):5623-5. PubMed ID: 16942036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
    Cohen A; Suzanne P; Lancelot JC; Verhaeghe P; Lesnard A; Basmaciyan L; Hutter S; Laget M; Dumètre A; Paloque L; Deharo E; Crozet MD; Rathelot P; Dallemagne P; Lorthiois A; Sibley CH; Vanelle P; Valentin A; Mazier D; Rault S; Azas N
    Eur J Med Chem; 2015 May; 95():16-28. PubMed ID: 25791675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines.
    Priebbenow DL; Mathiew M; Shi DH; Harjani JR; Beveridge JG; Chavchich M; Edstein MD; Duffy S; Avery VM; Jacobs RT; Brand S; Shackleford DM; Wang W; Zhong L; Lee G; Tay E; Barker H; Crighton E; White KL; Charman SA; De Paoli A; Creek DJ; Baell JB
    J Med Chem; 2021 Apr; 64(7):4150-4162. PubMed ID: 33759519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and evaluation of antimalarial properties of novel 4-aminoquinoline hybrid compounds.
    Fisher GM; Tanpure RP; Douchez A; Andrews KT; Poulsen SA
    Chem Biol Drug Des; 2014 Oct; 84(4):462-72. PubMed ID: 24720445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.